Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs EchoGo Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
EchoGo Pro
by Ultromics

AI Verdict

Tool A is designed for real-time prediction and management of intraoperative hypotension, providing continuous hemodynamic insights for acute care settings. In contrast, Tool B focuses on automating the analysis of stress echocardiograms to diagnose coronary artery disease, offering rapid, accurate diagnostic reports from imaging data. Therefore, while both leverage AI in cardiology, they serve distinct clinical purposes: acute event prediction versus diagnostic imaging analysis.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary goal is to proactively prevent and manage intraoperative or critical care hypotension. This tool is ideal for clinicians needing real-time, predictive insights into a patient's hemodynamic stability and the underlying causes of potential hypotensive events, enabling timely interventions to optimize patient outcomes in acute settings.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose EchoGo Pro if…

Choose EchoGo Pro if you aim to enhance the efficiency and accuracy of stress echocardiography analysis for diagnosing coronary artery disease. This cloud-based AI solution is best suited for cardiology departments seeking to automate image interpretation, reduce reporting times, and improve diagnostic consistency across their patient population with near-instant, comprehensive reports.

View EchoGo Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform EchoGo Pro
Pricing Unknown Contact vendor for pricing
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Cloud-based (SaaS)
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoGo Pro

EchoGo Pro (Tool B) is a cloud-based, vendor-neutral SaaS solution that requires no software installation or extensive training, making it highly adaptable and easy to integrate into existing clinical workflows (DICOM, HL7). In contrast, Acumen HPI (Tool A) is integrated with a specific hardware platform (Edwards Lifesciences HemoSphere) and dedicated sensors, which may present more deployment complexities.

Clinical Value

Tie

Both tools offer significant clinical value in their respective domains. Acumen HPI (Tool A) provides predictive insights into hypotensive events up to 15 minutes in advance, enabling proactive management and potentially reducing adverse outcomes. EchoGo Pro (Tool B) automates stress echocardiography analysis to improve the diagnosis of coronary artery disease, enhancing diagnostic accuracy and efficiency. Each addresses critical needs with distinct, high-impact benefits.

Pricing & Value

EchoGo Pro

While both tools require contacting the vendor for pricing, EchoGo Pro (Tool B) explicitly mentions the availability of reimbursement codes for related EchoGo products. This indicates a clearer understanding and pathway for healthcare providers to realize financial value and potentially offset costs, which is not detailed for Acumen HPI (Tool A) in the provided information.

Enterprise Readiness

EchoGo Pro

Both tools are HIPAA compliant and FDA cleared. However, EchoGo Pro (Tool B) is a cloud-based, vendor-neutral system compatible with any PACS and offers seamless integration with existing clinical workflows (DICOM, HL7), along with a Business Associate Agreement (BAA). This makes it more broadly adaptable and easier to deploy within diverse enterprise IT environments compared to Acumen HPI (Tool A), which is integrated with a specific Edwards Lifesciences hardware platform.

Innovation

Tie

Both tools demonstrate significant innovation by leveraging AI/ML to address complex clinical challenges. Acumen HPI (Tool A) innovates by providing real-time, predictive analytics for acute hypotensive events, offering insights into underlying hemodynamic causes. EchoGo Pro (Tool B) innovates by automating and standardizing the interpretation of complex echocardiogram images for CAD diagnosis, improving accuracy and efficiency. Both represent advanced applications of AI in healthcare.

Support & Docs

Tie

Based on the available information, both companies appear to provide standard documentation required for medical devices. Ultromics (Tool B) explicitly mentions a 'Clinician User Manual' and 'Operator Manual' with an overview of operator training. Edwards Lifesciences (Tool A) provides 'Frequently asked questions' and refers to 'instructions for use'. Without further details on the scope, accessibility, or quality of their support services, it is not possible to definitively distinguish between the two.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform EchoGo Pro
Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform EchoGo Pro
Company Edwards Lifesciences Ultromics
Primary Function Predicts hypotensive events up to 15 minutes in advance, providing insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension. Automates stress echocardiography analysis to improve the diagnosis of coronary artery disease, providing near-instant, accurate reports.
Key Technology Machine learning-based algorithm AI-powered automated echocardiogram analysis
Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology
Prediction/Analysis Output HPI Parameter (0-100 likelihood score), Smart Alerts for trending hypotension, Smart Trend screen, Relationship View screen (preload, afterload, contractility insights). Predicts hypotension up to 15 minutes in advance. Automated identification of coronary artery disease (CAD), near-instant, comprehensive reports.
Integration/Compatibility Integrated with Edwards Lifesciences HemoSphere Advanced Monitoring Platform via dedicated sensors. Vendor-neutral system, compatible with any PACS. Seamless integration with existing clinical workflows (DICOM, HL7).

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and EchoGo Pro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI enhances workflow for anesthesiologists, critical care, and emergency medicine physicians by providing real-time, predictive insights into hemodynamic instability, allowing proactive intervention to prevent hypotension. It integrates directly into continuous patient monitoring, offering a 15-minute predictive window and insights into underlying causes like preload, afterload, and contractility. EchoGo Pro streamlines the workflow for cardiologists by automating stress echocardiography analysis, delivering near-instant, accurate reports for coronary artery disease diagnosis. This reduces manual analysis time and improves diagnostic consistency, fitting seamlessly into existing imaging review processes.
Acumen HPI is integrated with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, implying data flow within that ecosystem, which typically has its own mechanisms for data export or integration with EHRs. The insights are displayed on the monitoring platform itself. EchoGo Pro offers seamless integration with existing clinical workflows via DICOM and HL7, suggesting a robust capability to push automated analysis reports and relevant data directly into the patient's EHR and PACS. This allows for broad accessibility of diagnostic insights within the electronic record.
Acumen HPI uses a machine learning-based algorithm to predict hypotensive events up to 15 minutes in advance, with an internal validation demonstrating 89% specificity and 90% sensitivity 10 minutes before an event, and an AUC of 0.95. Clinical studies have shown it can significantly reduce the duration of intraoperative hypotension. EchoGo Pro has demonstrated a diagnostic performance of over 90% (AUROC) in trials, significantly reducing misdiagnoses compared to routine clinical practice, and in a reader study, clinicians performed significantly better with its aid. It has been validated through partnerships like the EVAREST trial with the NHS.
Acumen HPI directly supports real-time, acute decision-making for anesthesiologists and critical care physicians by predicting hemodynamic instability, allowing for proactive interventions to manage blood pressure. Its insights into preload, afterload, and contractility guide targeted therapy. EchoGo Pro aids cardiologists in diagnostic decision-making by automating and standardizing the analysis of stress echocardiograms, improving the accuracy and speed of coronary artery disease diagnosis. This supports efficient and reliable interpretation of complex imaging data.
The Acumen HPI, integrated with the Edwards Lifesciences monitoring platform, would require staff to learn the interpretation of the HPI parameter, smart alerts, and relationship view screen. Time-to-value would likely be immediate upon integration and staff training, as it provides real-time predictive insights. EchoGo Pro is described as requiring no software installation or extensive training due to its SaaS model, suggesting a minimal learning curve for physicians and staff. Its ability to provide near-instant reports implies a rapid time-to-value for enhanced diagnostic efficiency.
Multi-site rollout of Acumen HPI would involve integrating with existing or new Edwards Lifesciences HemoSphere/EV1000 platforms and dedicated sensors across each site, requiring hardware deployment and network considerations. Customer references would need to be requested directly from Edwards Lifesciences. EchoGo Pro, being a cloud-based SaaS solution with vendor-neutral PACS compatibility and DICOM/HL7 integration, would likely have fewer logistical hurdles for multi-site rollout, primarily focusing on network connectivity and data exchange protocols. Ultromics would be the source for customer references regarding implementation experiences.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or EchoGo Pro

AI Tool Finder
AI-powered search. Results may not be comprehensive.